Agilent Technologies, Inc.
A · NYSE · United States · Health Care · Pharma / Biotech / Life Sci
- Coverage
- FY2016–FY2025
- History
- 10 years
- Latest filing
- 10-K · SEC EDGAR
- Reporting
- USD
- Fiscal year end
- October
- Last updated
- Dec 2025
Headline figures
Agilent Technologies, Inc. at a glance
In FY2025, Agilent Technologies, Inc. reported revenue of USD 6,948 mn, EBITDA of USD 1,767 mn, EBITDA margin of 25.4%.
| USD mn | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 6,510 | 6,948 | |||
| EBITDA | 1,745 | 1,767 | |||
| EBITDA margin | 26.8% | 25.4% | |||
| Free cash flow | 1,373 | 1,152 | |||
| ROIC | 20.5% | 20.1% |
The full 10-year history, every line item and each formula are in the platform.
In the platform
- Stat Book — normalized and as-reported IS, BS and CF
- Up to 10 years of annual and quarterly history
- Peer benchmarking and the stock screener
- Corporate risk scorecard
- DCF model from the filed inputs
- Tearsheet and live Excel formulas